Serum miR-122 levels in the validation cohort and overall survival in the combined cohort.

<p>(<b>A</b>) Serum miR-122 in patients with and without hepatic decompensation. (<b>B</b>) miR-122 levels in patients with and without ascites. The vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile. The analysis was performed with Kruskal-Wallis test and the Bonferroni correction was used for the sub-analysis. The number of patients in each group is indicated in the figure. (<b>C</b>) Survival curves for patients in the validation cohort with high or low serum miR-122 levels. The analysis was performed with the Cox regression model. (<b>D</b>) Survival curves for patients in the combined cohort with high or low serum miR-122 levels. The analysis was performed with the Cox regression model.